Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Short term Debt (2020 - 2022)

Intelligent Bio Solutions has reported Short term Debt over the past 3 years, most recently at $1.0 million for Q3 2022.

  • For Q3 2022, Short term Debt rose 1380.81% year-over-year to $1.0 million; the TTM value through Sep 2022 reached $1.0 million, up 1380.81%, while the annual FY2022 figure was $2.8 million, 21190.87% up from the prior year.
  • Short term Debt for Q3 2022 was $1.0 million at Intelligent Bio Solutions, down from $2.8 million in the prior quarter.
  • Over five years, Short term Debt peaked at $5.1 million in Q2 2020 and troughed at $9536.0 in Q4 2021.
  • A 3-year average of $1.2 million and a median of $250214.5 in 2020 define the central range for Short term Debt.
  • Biggest five-year swings in Short term Debt: plummeted 99.74% in 2021 and later surged 21190.87% in 2022.
  • Year by year, Short term Debt stood at $431621.0 in 2020, then crashed by 97.79% to $9536.0 in 2021, then skyrocketed by 10584.96% to $1.0 million in 2022.
  • Business Quant data shows Short term Debt for INBS at $1.0 million in Q3 2022, $2.8 million in Q2 2022, and $9536.0 in Q4 2021.